Deferasirox
- Product NDC
- 70700-269
- 11-digit product format
- 707000269
- Labeler code
- 70700
- Product ID
- 70700-269_bb29f5e5-53df-4432-b6d1-854fa1e54d83
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Xiromed, LLC
- Application
- ANDA212995
- Marketing category
- ANDA
- Marketing start
- 2020-01-02
- Substance
- DEFERASIROX
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Deferasirox
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEFERASIROX | 90 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V8G4MOF2V9 |
| Rxcui | 1607784, 1607792, 1607796 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70700-269-30 | Deferasirox | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 15 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70700-269 | DEFERASIROX TABLET [XIROMED, LLC] | 15 | Current NDC, Legacy NDC, 1 package rows | 20240921_4c36bb5a-2552-46c1-8500-4ae783cffef1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70700-269-30 | 70700026930 | 30 TABLET in 1 BOTTLE, PLASTIC (70700-269-30) | 30 tablet | 2020-01-02 | 0000-00-00 | No | No | Current |